BioScience Trends. 2013;7(3):157-158. (DOI: 10.5582/bst.2013.v7.3.157)

Perspectives on human clinical trials of therapies using iPS cells in Japan: Reaching the forefront of stem-cell therapies.

Song PP, Inagaki Y, Sugawara Y, Kokudo N


A research project involving sheets of retinal pigment epithelium constructed from iPS cells derived from patients with age-related maculopathy is one step closer to being approved for clinical trials by the Japanese Government. Now is the time to make therapies using iPS cells clinically available.

KEYWORDS: Induced pluripotent stem cell, age-related maculopathy, clinical trial

Full Text: